1. Takeda H, Nagai S, Ikeda D, Kaneko S, Tsuji T, Fujita N. Collagen profiling of ligamentum flavum in patients with lumbar spinal canal stenosis. J Orthop Sci 2021 26:560–5.
2. Sairyo K, Biyani A, Goel VK, et al. Lumbar ligamentum flavum hypertrophy is due to accumulation of inflammation-related scar tissue. Spine (Phila Pa 1976) 2007 32:E340–7.
3. Park JO, Lee BH, Kang YM, et al. Inflammatory cytokines induce fibrosis and ossification of human ligamentum flavum cells. J Spinal Disord Tech 2013 26:E6–12.
5. Zhang Y, Chen J, Zhong ZM, Yang D, Zhu Q. Is platelet-derived growth factor-BB expression proportional to fibrosis in the hypertrophied lumber ligamentum flavum? Spine (Phila Pa 1976) 2010 35:E1479–86.
9. Lakemeier S, Schofer MD, Foltz L, et al. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, and matrix metalloproteinases 1, 3, and 9 in hypertrophied ligamentum flavum. J Spinal Disord Tech 2013 26:400–6.
10. Kim BJ, Hur JW, Park JS, et al. Expression of matrix metalloproteinase-2 and -9 in human ligamentum flavum cells treated with tumor necrosis factor-α and interleukin-1β. J Neurosurg Spine 2016 24:428–35.
12. Oh IS, Ha KY. Matrix metalloproteinase-3 on ligamentum flavum in degenerative lumbar spondylolisthesis. Spine (Phila Pa 1976) 2009 34:E552–7.
13. Yabe Y, Hagiwara Y, Ando A, et al. Chondrogenic and fibrotic process in the ligamentum flavum of patients with lumbar spinal canal stenosis. Spine (Phila Pa 1976) 2015 40:429–35.
14. Park JB, Chang H, Lee JK. Quantitative analysis of transforming growth factor-beta 1 in ligamentum flavum of lumbar spinal stenosis and disc herniation. Spine (Phila Pa 1976) 2001 26:E492–5.
15. Delen E, Doganlar O, Delen O, Doganlar ZB, Kilincer C. The role of JAK-STAT signaling activation in hypertrophied ligamentum flavum. World Neurosurg 2020 137:e506–16.
16. Xu L, Peng H, Wu D, et al. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J Biol Chem 2005 280:548–55.
21. Vogel W, Gish GD, Alves F, Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1997 1:13–23.
25. Jablonska-Trypuc A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem 2016 31(sup1): 177–83.
28. Saito T, Hara M, Kumamaru H, et al. Macrophage infiltration is a causative factor for ligamentum flavum hypertrophy through the activation of collagen production in fibroblasts. Am J Pathol 2017 187:2831–40.